145 related articles for article (PubMed ID: 12757501)
1. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001.
Soldan K; Barbara JA; Ramsay ME; Hall AJ
Vox Sang; 2003 May; 84(4):274-86. PubMed ID: 12757501
[TBL] [Abstract][Full Text] [Related]
2. Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010.
Kim MJ; Park Q; Min HK; Kim HO
BMC Infect Dis; 2012 Jul; 12():160. PubMed ID: 22817275
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus.
de Almeida-Neto C; Sabino EC; Liu J; Blatyta PF; Mendrone-Junior A; Salles NA; Leão SC; Wright DJ; Basques FV; Ferreira JE; Busch MP; Murphy EL;
Transfusion; 2013 Apr; 53(4):827-34. PubMed ID: 22882510
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, incidence and residual risk of transfusion transmitted viruses (HBV, HCV and HIV infections) in Lithuanian blood donors from 2004 to 2018: The incidence/window-period model study.
Grubyte S; Urboniene J; Nedzinskiene L; Jelinskaite A; Zagminas K; Ambrozaitis A; Jancoriene L
PLoS One; 2021; 16(2):e0246704. PubMed ID: 33606700
[TBL] [Abstract][Full Text] [Related]
5. Progress toward prevention of transfusion-transmitted hepatitis B and hepatitis C infection--sub-Saharan Africa, 2000-2011.
Apata IW; Averhoff F; Pitman J; Bjork A; Yu J; Amin NA; Dhingra N; Kolwaite A; Marfin A;
MMWR Morb Mortal Wkly Rep; 2014 Jul; 63(29):613-9. PubMed ID: 25055184
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence & changing trends of transfusion-transmitted infections amongst blood donors in a Regional Blood Transfusion Centre in north India.
Rawat A; Diwaker P; Gogoi P; Singh B
Indian J Med Res; 2017 Nov; 146(5):642-645. PubMed ID: 29512607
[TBL] [Abstract][Full Text] [Related]
7. Advancing blood transfusion safety using molecular detection in the country of Georgia.
Alkhazashvili M; Bloch EM; Shadaker S; Kuchuloria T; Getia V; Turdziladze A; Armstrong PA; Gamkrelidze A
Transfus Clin Biol; 2023 Aug; 30(3):307-313. PubMed ID: 36907246
[TBL] [Abstract][Full Text] [Related]
8. Evolution of the residual risk of HBV, HCV and HIV transmission through blood transfusion in the Region of Valencia, Spain, during a 15-year period (2003-2017).
López-Menchero C; Alvarez M; Fernández P; Guzmán M; Ortiz-de-Salazar MI; Arbona C
Blood Transfus; 2019 Nov; 17(6):418-427. PubMed ID: 31403928
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, incidence, risk factors and residual risk associated with viral infections among eligible Brazilian blood donors.
Santos APA; Rios DRA; Trindade CLC; Oliveira FEG; Oliveira MB; de Melo SN; Belo VS
Transfus Med; 2024 Feb; 34(1):46-53. PubMed ID: 38165014
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of transfusion-transmitted infections in Saudi Arabia blood donors: A nationwide, cross-sectional study.
Alsughayyir J; Almalki Y; Alburayk I; Alalshaik M; Aljoni I; Kandel M; Alfhili MA; Alabdullateef AA
Saudi Med J; 2022 Dec; 43(12):1363-1372. PubMed ID: 36517064
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance.
Laperche S; Sauvage C; Gallian P; Jbilou S; Pouchol E; Py JY; Chabli L; Richard P; Morel P; Lot F; Tiberghien P
Vox Sang; 2023 Oct; 118(10):843-853. PubMed ID: 37694766
[TBL] [Abstract][Full Text] [Related]
12. Clinical performance of a new multiplex assay for the detection of HIV-1, HIV-2, HCV, HBV, and HEV in blood donations in Catalonia (Spain).
Sauleda S; Bes M; Piron M; Ong E; Coco SB; Carrió J; Linnen JM
Transfusion; 2023 Nov; 63(11):2098-2105. PubMed ID: 37767741
[TBL] [Abstract][Full Text] [Related]
13. Changes in transfusion-transmissible infection prevalence and demographics among US blood donors during the COVID-19 pandemic.
Conti G; Notari EP; Dodd RY; Kessler D; Custer B; Bruhn R; Reik R; Yang H; Whitaker BI; Stramer SL;
Transfusion; 2024 Jun; 64(6):1040-1049. PubMed ID: 38661249
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study-II blood centers in Brazil.
Sabino EC; Gonçalez TT; Carneiro-Proietti AB; Sarr M; Ferreira JE; Sampaio DA; Salles NA; Wright DJ; Custer B; Busch M;
Transfusion; 2012 Apr; 52(4):870-9. PubMed ID: 21981109
[TBL] [Abstract][Full Text] [Related]
15. Degree of blood safety of voluntary non-remunerated versus replacement blood donations: A multi-centre study of the large cohort of blood donors from two provinces of Pakistan.
Jamal S; Mansoor N; Ali A; Nadeem A; Aijaz J; Meraj F
Vox Sang; 2023 Dec; 118(12):1078-1085. PubMed ID: 37850301
[TBL] [Abstract][Full Text] [Related]
16. Development of a risk prediction score for screening for HBV, HCV and HIV among migrants in France: results from a multicentre observational study (STRADA study).
Duracinsky M; Yaya I; Yombo-Kokule L; Bessonneau P; Thonon F; Rousset-Torrente O; Roudot-Thoraval F; Lert F; Zucman D; Chassany O
BMJ Open; 2024 Jun; 14(6):e075315. PubMed ID: 38839381
[TBL] [Abstract][Full Text] [Related]
17. Removing hepatitis C antibody testing for Australian blood donations: A cost-effectiveness analysis.
Cheng Q; Hoad VC; Roy Choudhury A; Seed CR; Bentley P; Shih STF; Kwon JA; Gray RT; Wiseman V
Vox Sang; 2023 Jun; 118(6):471-479. PubMed ID: 37183482
[TBL] [Abstract][Full Text] [Related]
18. Is dual testing for hepatitis C necessary? Modelling the risk of removing hepatitis C antibody testing for Australian blood donations.
Roy Choudhury A; Hoad VC; Seed C; Bentley P
Vox Sang; 2023 Jun; 118(6):480-487. PubMed ID: 37183505
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, incidence, and residual risks for transfusion-transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors.
Wang J; Liu J; Yao F; Wen G; Li J; Huang Y; Lü Y; Wen X; Wright D; Yu Q; Guo N; Ness P; Shan H;
Transfusion; 2013 Jun; 53(6):1240-9. PubMed ID: 23113801
[TBL] [Abstract][Full Text] [Related]
20. Infectious etiologies among post-donation deferrals in a military blood donation center.
Kwon S; Casleton BG; Rivera GZ; Gella MM; Winkler EL; Kieffer JW; Osuna AB; Casey TM; Yun HC; Marcus JE
Transfusion; 2023 Dec; 63(12):2265-2272. PubMed ID: 37850496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
